Rb1 postconditioning attenuates liver warm ischemia-reperfusion injury through ROS-NO-HIF pathway

Life Sciences

Volumn 88, Issue 13-14, 2011, Pages 598-605

  Guo, Yingjia ^a   Yang, Tong ^a   Lu, Jun ^a   Li, Shengfu ^a   Wan, Lin ^a   Long, Dan ^a   Li, Quansheng ^a   Feng, Li ^a   Li, Youping ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Ginsenoside Rb1; HIF 1alpha; Ischemia reperfusion; Nitric oxide; Reactive oxygen species

Indexed keywords

ALANINE AMINOTRANSFERASE; GINSENOSIDE RB 1; HYPOXIA INDUCIBLE FACTOR 1; INTERCELLULAR ADHESION MOLECULE 1; MALONALDEHYDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; ISCHEMIC POSTCONDITIONING; LIVER ISCHEMIA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REPERFUSION INJURY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BODY TEMPERATURE; DISEASE MODELS, ANIMAL; GINSENOSIDES; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; ISCHEMIC POSTCONDITIONING; LIVER; LIVER FUNCTION TESTS; MALE; MICE; MICE, INBRED BALB C; NECROSIS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY;

MUS;

EID: 79952698977     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.01.022     Document Type: Article

References (56)

1. Addya S, Shiroto K, Turoczi T, Zhan L, Kaga S, Fukuda S, et al. Ischemic preconditioning mediated cardio protection is disrupted in heterozygous Flt-1 (VEGFR-1) knockout mice. J Mol Cell Cardiol 2005;38:345-51. (Pubitemid 40215204)
2. Alchera E, Tacchini L, Imarisio C, Dal Ponte C, De Ponti C, Gammella E, et al. Adenosine-dependent activation of hypoxia-inducible factor-1 induces late preconditioning in liver cells. Hepatology 2008;48:230-9. (Pubitemid 351975548)
3. Borges MM, Kloetzel JK, Andrade Jr HF, Tadokoro CE, Pinge-Filho P, Abrahamsohn I. Prostaglandin and nitric oxide regulate TNF-alpha production during Trypanosoma cruzi infection. Immunol Lett 1998;63(1):1-8. (Pubitemid 28368237)
4. Brüne B, Zhou J. The role of nitric oxide (NO) in stability regulation of hypoxia inducible factor-1alpha (HIF-1alpha). Curr Med Chem 2003;10:845-55.
5. Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H, Zweier JL, Semenza GL. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 2003;108:79-85. (Pubitemid 36859024)
6. Fujii H, Ichimori K, Hoshiai K, Nakazawa H. Nitric oxide inactivates NADPH oxidase in pig neutrophils by inhibiting its assembling process. J Biol Chem 1997;272:32773-8. (Pubitemid 28023609)
7. Fujita K, Hakuba N, Hata R, Morizane I, Yoshida T, Shudou M, et al. Ginsenoside Rb1 protects against damage to the spiral ganglion cells after cochlear ischemia. Neurosci Lett 2007;415:113-7. (Pubitemid 46386327)
8. Geng Q, Wu D, Xie YC, Zhang BG, Wu H, Yin WH. Effects of ginsenoside Rb1 on apoptosis and Bcl-2, Bax gene expression in rabbits with lung ischemia/reperfusion injury. Chin J Integr Tradit West Med Intensive Crit Care 2005;12:159-61.
9. Hines IN, Harada H, Bharwani S, Pavlick KP, Hoffman JM, Grisham MB. Enhanced post-ischemic liver injury in iNOS-deficient mice: a cautionary note. Biochem Biophys Res Commun 2001;284:972-6. (Pubitemid 32924743)
10. Hines IN, Kawachi S, Harada H, Pavlick KP, Hoffman JM, Bharwani S, et al. Role of nitric oxide in liver ischemia and reperfusion injury. Mol Cell Biochem 2002;234-235:229-37. (Pubitemid 34777862)
11. Hsu CM, Wang JS, Liu CH, Chen LW. Kupffer cells protect liver from ischemia-reperfusion injury by an inducible nitric oxide synthase-dependent mechanism. Shock 2002;17:280-5.
12. Jaeschke H, Leamsters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/ reperfusion injury. Gastroenterology 2003;125:1246-57. (Pubitemid 37193469)
13. Jalowy A, Schulz R, Heusch G. AT1 receptor blockade in experimental myocardial ischemia/reperfusion. J Am Soc Nephrol 1999;10:S129-36.
14. Jiang MZ, Tsukahara H, Ohshima Y, Todoroki Y, Hiraoka M, Maeda M, et al. Effects of antioxidants and nitric oxide on TNF-alpha-induced adhesion molecule expression and NF-kappaB activation in human dermal microvascular endothelial cells. Life Sci 2004;75:1159-70. (Pubitemid 38829341)
15. Kaizu T, Ikeda A, Nakao A, Takahashi Y, Tsung A, Kohmoto J, et al. Donor graft adenoviral iNOS gene transfer ameliorates rat liver transplant preservation injury and improves survival. Hepatology 2006;43:464-73.
16. Kasuno K, Takabuchi S, Fukuda K, Kizaka-Kondoh S, Yodoi J, Adachi T, et al. Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAPK and phosphatidylinositol 3-kinase signaling. J Biol Chem 2004;279:2550-8. (Pubitemid 38114240)
17. Kojda G, Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 1999;43:562-71. (Pubitemid 29369255)
18. Kubota I, Han X, Opel DJ, Zhao YY, Baliga R, Huang P, et al. Increased susceptibility to development of triggered activity in myocytes from mice with targeted disruption of endothelial nitric oxide synthase. J Mol Cell Cardiol 2000;32:1239-48.
19. Lang Jr JD, Teng X, Chumley P, Crawford JH, Isbell TS, Chacko BK, et al. Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest 2007;117:2583-91. (Pubitemid 47494359)
20. Lee H-U, Bae E-A, Han MJ, Kim N-J, Kim D-H. Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury. Liver Int 2005;25:1069-73. (Pubitemid 41404031)
21. Lefer DJ. Induction of HIF-1alpha and iNOS with siRNA: a novel mechanism for myocardial protection. Circ Res 2006;98:10-1. (Pubitemid 43970198)
22. Li F, Sonveaux P, Rabbani ZN, Liu S, Yan B, Huang Q, et al. Regulation of HIF-1alpha stability through S-nitrosylation. Mol Cell 2007;26:63-74. (Pubitemid 46550936)
23. Lindemann S, Sharafi M, Spiecker M, Buerke M, Fisch A, Grosser T, et al. NO reduces PMN adhesion to human vascular endothelial cells due to downregulation of ICAM-1 mRNA and surface expression. Thromb Res 2000;97:113-23. (Pubitemid 30055276)
24. Liu P, Xu B, Hock CE, Nagele R, Sun FF, Wong PY. NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R. Am J Physiol 1998;275:H2191-8.
25. Lu DY, Liou HC, Tang CH, Fu WM. Hypoxia-induced iNOS expression in microglia is regulated by the PI3-kinase/Akt/mTOR signaling pathway and activation of hypoxia inducible factor-1alpha. Biochem Pharmacol 2006;72:992-1000.
26. Luciano JA, Tan T, Zhang Q, Huang E, Scholz P, Weiss HR. Hypoxia inducible factor-1 improves the actions of nitric oxide and natriuretic peptides after simulated ischemia-reperfusion. Cell Physiol Biochem 2008;21:421-8. (Pubitemid 351620295)
27. Luo Y, Jiang C, Belanger AJ, Akita GY, Wadsworth SC, Gregory RJ, et al. A constitutively active hypoxiainducible factor-1alpha/vp16 hybrid factor activates expression of the human b-type natriuretic peptide gene. Mol Pharmacol 2006;69:1953-62.
28. Mateo J, Garcia-Lecea M, Cadenas S, Hernandez C, Moncada S. Regulation of hypoxia-inducible factor-1 and independent pathways. Biochem J 2003;376:537-44.
29. Meldrum DR, Shenkar R, Sheridan BC, Cain BS, Abraham E, Harken AH. Hemorrhage activates myocardial NFkB and increases tumor necrosis factor in the heart. J Mol Cell Cardiol 1997;29:2849-54. (Pubitemid 27466506)
30. Meldrum DR, Dinarello CA, Cleveland Jr JC, Cain BS, Shames BD, Meng X. Hydrogen peroxide induces tumor necrosis factor alpha-mediated cardiac injury by a P38mitogen-activated protein kinase-dependent mechanism. Surgery 1998;124:291-7. (Pubitemid 28372929)
31. Metzen E, Zhou J, Jelkmann W, Fandrey J, Brüne B. Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Mol Biol Cell 2003;14:3470-81. (Pubitemid 37013142)
32. Murphy ME, Sies H. Reversible conversion of nitroxyl anion to nitric oxide by superoxide dismutase. Proc Natl Acad Sci USA 1991;88:10860-4. (Pubitemid 21915938)
33. Ockaili R, Natarajan R, Salloum F, Fisher BJ, Jones D, Fowler AA, et al. HIF-1 activation attenuates post-ischemic myocardial injury: a role for heme oxygenase-1 in modulating microvascular chemokine generation. Am J Physiol Heart Circ Physiol 2005;289:H542-8.
34. Patel A, van de Poll MC, Greve JW, Buurman WA, Fearon KC, McNally SJ, et al. Early stress protein gene expression in a human model of ischemic preconditioning. Transplantation 2004;78:1479-87.
35. Peralta C, Perales JC, Bartrons R, Mitchell C, Gilgenkrantz H, Xaus C. The combination of ischemic preconditioning and liver Bcl-2 overexpression is a suitable strategy to prevent liverand lung damage after hepatic ischemia-reperfusion. Am J Pathol 2002;160:2111-22. (Pubitemid 34663403)
36. Ronson RS, Nakamura M, Vinten-Johansen J. The cardiovascular effects and implications of peroxynitrite. Cardiovasc Res 1999;44:47-59. (Pubitemid 29431683)
37. Salloum F, Yin C, Xi L, Kukreja RC. Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart. Circ Res 2003;92:595-7. (Pubitemid 36417692)
38. Sandau KB, Faus HG, Brune B. Induction of hypoxia-inducible-factor 1 by nitric oxide is mediated via the PI 3 K pathway. Biochem Biophys Res Commun 2000;278:263-7.
39. Scott GI, Colligan PB, Ren BH, Ren J. Ginsenosides Rb1 and Re decrease cardiac contraction in adult rat ventricular myocytes: role of nitric oxide. Br J Pharmacol 2001;134:1159-65. (Pubitemid 33097245)
40. Shimamura T, Zhu Y, Zhang S, Jin MB, Ishizaki N, Urakami A, et al. Protective role of nitric oxide in ischemia and reperfusion injury of the liver. J Am Coll Surg 1999;188:43-52. (Pubitemid 29031969)
41. Shoskes DA, Halloran PF. Delayed graft function in renal transplantation. Etiology, management and long-term significance. The Journal of Urology 1996;155:1837-40.
42. Singh I, Gulati S, Orak JK, Singh AK. Expression of antioxidant enzymes in rat kidney during ischemia-reperfusion injury. Mol Cell Biochem 1993;125:97-104. (Pubitemid 23312726)
43. Sumbayev VV, Budde A, Zhou J, Brune B.HIF-1 alpha protein as a target for S-nitrosation. FEBS Lett 2003;535:106-12. (Pubitemid 36126364)
44. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497-500.
45. Takeda K, Jin MB, Fujita M, Fukai M, Sakurai T, Nakayama M, et al. A novel inhibitor of Rho-associated protein kinase, Y-27632, ameliorates hepatic ischemia and reperfusion injury in rats. Surgery 2003;133:197-206. (Pubitemid 36407984)
46. Taylor BS, Alarcon LH, Billiar TR. Inducible nitric oxide synthase in the liver: regulation and function. Biochemistry (Moscow) 1998;63:766-81. (Pubitemid 128588106)
47. Wang Y, Lawson JA, Jaeschke H. Differential effect of 2-aminoethylisothiourea, an inhibitor of the inducible nitric oxide synthase, on microvascular blood flow and organ injury in models of hepatic ischemia-reperfusion and endotoxemia. Shock 1998;10:20-5. (Pubitemid 128463258)
48. Wang J, Qiao L, Li Y, Yang G. Ginsenoside Rb1 attenuates intestinal ischemia-reperfusion-induced liver injury by inhibiting NF-kappaB activation. Exp Mol Med 2008;40:686-98.
49. Xi L, Taher M, Yin C, Salloum F, Kukreja RC. Cobalt chloride induces delayed cardiac preconditioning in mice through selective activation of HIF-1alpha and AP-1 and iNOS signaling. Am J Physiol Heart Circ Physiol 2004;287:H2369-75.
50. Xie YW, Kaminski PM, Wolin MS. Inhibition of rat cardiac muscle contraction and mitochondrial respiration by endogenous peroxynitrite formation during posthypoxic reoxygenation. Circ Res 1998;82:891-7. (Pubitemid 28234580)
51. Yabe Y, Kobayashi N, Nishihashi T, Takahashi R, Nishikawa M, Takakura Y, et al. Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives. J Pharmacol Exp Ther 2001;298:894-9. (Pubitemid 32761901)
52. Yu J, Eto M, Akishita M, Kaneko A, Ouchi Y, Okabe T. Signaling pathway of nitric oxide production induced by ginsenoside Rb1 in human aortic endothelial cells: a possible involvement of androgen receptor. Biochem Biophys Res Commun 2007;353:764-9. (Pubitemid 46048736)
53. Yuan QL, Yang CX, Xu P, Gao XQ, Deng L, Chen P, et al. Neuroprotective effects of ginsenoside Rb1 on transient cerebral ischemia in rats. Brain Res 2007;1167:1-12. (Pubitemid 47302431)
54. Zeng HS, Liu ZX, Liu XC. Effect of ginsenoside-Rb1 and Re against cardiomyocyte apoptosis and expression of the related gene proteins in the experimental cardiac ischemiareperfusion in rats. Chin J Phys Med Rehabil 2003;25:402-5.
55. Zhang B, Matsuda S, Tanaka J, Tateishi N, Maeda N, Wen TC, et al. Ginsenoside Rb1 prevents image navigation disability, cortical infarction, and thalamic degeneration in rats with focal cerebral ischemia. J Stroke Cerebrovasc Dis 1998;7:1-9.
56. Zhong Z, Ramshesh VK, Rehman H, Currin RT, Sridharan V, Theruvath TP, et al. Activation of the oxygen-sensing signal cascade prevents mitochondrial injury after mouse liver ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 2008;295:G823-32.